Clinical TopicsWeb Exclusives

FDA approves first treatment for pediatric patients with lupus

Share

On April 26, the FDA approved Benlysta (belimumab) I.V. infusion for treatment of children with systemic lupus erythematosus (SLE). This is the first FDA-approved treatment for pediatric patients with SLE.

Read more at fda.gov.

Test Your Knowledge

Which type of skin cancer is the deadliest, despite accounting for only 1% of all skin cancer cases?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts